PRME vs SWKS · rev $4.6M vs P/E 29, rev $4.09B
Prime Medicine, Inc. Common Stock (PRME) versus Skyworks Solutions Inc (SWKS) — a side-by-side from cached financials, not a winner call.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Skyworks Solutions Inc (SWKS) is a semiconductors company listed on NASDAQ.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
Latest reported SWKS revenue for 2025-10-03 was $4.09B. Net income was $477.1M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
PRME currently screens at market cap $570.8M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
Not investment advice. Open the PRME and SWKS stock pages for the full models.
Not investment advice.